Jan-Paul Simard
Co-Chief Executive Officer
Jan-Paul Simard began his career at XBiotech in 2012 in Research and Development as a Research Associate. Mr. Simard transitioned to Clinical Development in 2020, contributing to clinical trial design and protocol development across multiple therapeutic indications, including pancreatic cancer, non-small cell lung cancer, osteoarthritis, and rheumatoid arthritis. He attended the University of Saskatchewan, double majoring in Chemistry and Biomedical Sciences with Honours, where his focus was organic synthesis and analysis of gluconeogenic enzyme mechanisms. In 2026, Mr. Simard left the University of Saskatchewan to take the position of Co-Chief Executive Officer alongside Dr. Shivaswamy.